Involvement of mutation in ampD I, mrcA, and at least one additional gene in β-lactamase hyperproduction in Stenotrophomonas maltophilia

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 11, 2013, Pages 5486-5491

  Talfan, Asmaa ^a   Mounsey, Oliver ^a   Charman, Matthew ^a   Townsend, Eleanor ^a   Avison, Matthew B ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CEFTAZIDIME;

AMPD 1 GENE; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIUM ISOLATE; BACTERIUM MUTANT; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENE DISRUPTION; GENE MUTATION; MRCA GENE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STENOTROPHOMONAS MALTOPHILIA; WILD TYPE;

BACTERIAL PROTEINS; BETA-LACTAMASES; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC COMPLEMENTATION TEST; GENOTYPE; HUMANS; MUTATION; N-ACETYLMURAMOYL-L-ALANINE AMIDASE; PEPTIDOGLYCAN; PHENOTYPE; PROTEOLYSIS; STENOTROPHOMONAS MALTOPHILIA;

EID: 84885910293     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01446-13     Document Type: Article

References (37)

1. Ryan RP, Monchy S, Cardinale M, Taghavi S, Crossman L, Avison MB, Berg G, van der Lelie D, Dow JM. 2009. The versatility and adaptation of bacteria from the genus Stenotrophomonas. Nat. Rev. Microbiol. 7:514-525.
2. Looney WJ, Narita M, Mühlemann K. 2009. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect. Dis. 9:312-323.
3. Okazaki A, Avison MB. 2008. Induction of L1 and L2 β-lactamase production in Stenotrophomonas maltophilia is dependent on an AmpR-type regulator. Antimicrob. Agents Chemother. 52:1525-1528.
4. Jacobs C, Frère JM, Normark S. 1997. Cytosolic intermediates for cell wall biosynthesis and degradation control inducible β-lactam resistance in gram-negative bacteria. Cell 88:823-832.
5. Jacobs C, Huang LJ, Bartowsky E, Normark S, Park JT. 1994. Bacterial cell wall recycling provides cytosolic muropeptides as effectors for β-lactamase induction. EMBO J. 13:4684-4694.
6. Sanders CC, Bradford PA, Ehrhardt AF, Bush K, Young KD, Henderson TA, Sanders WE, Jr. 1997. Penicillin-binding proteins and induction of AmpC β-lactamase. Antimicrob. Agents Chemother. 41:2013-2015.
7. Nicodemo AC, Paez JI. 2007. Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur. J. Clin. Microbiol. Infect. Dis. 26:229-237.
8. Gould VC, Okazaki A, Avison MB. 2006. β-Lactam resistance and β-lactamase expression in clinical Stenotrophomonas maltophilia isolates having defined phylogenetic relationships. J. Antimicrob. Chemother. 57: 199-203.
9. Kopp U, Wiedemann B, Lindquist S, Normark S. 1993. Sequences of wild-type and mutant ampD genes of Citrobacter freundii and Enterobacter cloacae. Antimicrob. Agents Chemother. 37:224-228.
10. Moya B, Dötsch A, Juan C, Blázquez J, Zamorano L, Haussler S, Oliver A. 2009. β-Lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein. PLoS Pathog. 5:e1000353. doi:10.1371/journal.ppat.1000353.
11. Tayler AE, Ayala JA, Niumsup P, Westphal K, Baker JA, Zhang L, Walsh TR, Wiedemann B, Bennett PM, Avison MB. 2010. Induction of β-lactamase production in Aeromonas hydrophila is responsive to β-lactam-mediated changes in peptidoglycan composition. Microbiology 156: 2327-2335.
12. Crossman LC, Gould VC, Dow JM, Vernikos GS, Okazaki A, Sebaihia M, Saunders D, Arrowsmith C, Carver T, Peters N, Adlem E, Kerhornou A, Lord A, Murphy L, Seeger K, Squares R, Rutter S, Quail MA, Rajandream MA, Harris D, Churcher C, Bentley SD, Parkhill J, Thomson NR, Avison MB. 2008. The complete genome, comparative, and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol. 9:R74.
13. Juan C, Moyá B, Pérez JL, Oliver A. 2006. Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring highlevel β-lactam resistance involves three AmpD homologues. Antimicrob. Agents Chemother. 50:1780-1787.
14. Yang TC, Huang YW, Hu RM, Huang SC, Lin YT. 2009. AmpDI is involved in expression of the chromosomal L1 and L2 β-lactamases of Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 53:2902-2907.
15. Lin CW, Lin HC, Huang YW, Chung TC, Yang TC. 2011. Inactivation of mrcA gene derepresses the basal-level expression of L1 and L2 β-lactamases in Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 66: 2033-2037.
16. Avison MB, von Heldreich CJ, Higgins CS, Bennett PM, Walsh TR. 2000. A TEM-2 β-lactamase encoded on an active Tn1-like transposon in the genome of a clinical isolate of Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 46:879-884.
17. Okazaki A, Avison MB. 2007. Aph(3')-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 51:359-360.
18. Fouhy Y, Scanlon K, Schouest K, Spillane C, Crossman L, Avison MB, Ryan RP, Dow JM. 2007. Diffusible signal factor-dependent cell-cell signaling and virulence in the nosocomial pathogen Stenotrophomonas maltophilia. J. Bacteriol. 189:4964-4968.
19. Rouf R, Karaba SM, Dao J, Cianciotto NP. 2011. Stenotrophomonas maltophilia strains replicate and persist in the murine lung, but to significantly different degrees. Microbiology 157:2133-2142.
20. Gould VC, Okazaki A, Avison MB. 2013. Coordinate hyper-production of SmeZ and SmeJK efflux pumps extends drug resistance in Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 57:655-657.
21. Toleman MA, Bennett PM, Bennett DM, Jones RN, Walsh TR. 2007. Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes. Emerg. Infect. Dis. 13:559-565.
22. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H. 2006. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol. 2:2006-2008.
23. Andrews JM, Howe RA. 2011. BSAC standardized disc susceptibility testing method (version 10). J. Antimicrob. Chemother. 66:2726-2757.
24. Avison MB, Higgins CS, Ford PJ, von Heldreich CJ, Walsh TR, Bennett PM. 2002. Differential regulation of L1 and L2 β-lactamase expression in Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 49:387-389.
25. Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; 9th ed. Approved standard M07-A9. CLSI, Wayne, PA.
26. Avison MB, Underwood S, Okazaki A, Walsh TR, Bennett PM. 2004. Analysis of AmpC β-lactamase expression and sequence in biochemically atypical ceftazidime-resistant Enterobacteriaceae from paediatric patients. J. Antimicrob. Chemother. 53:584-591.
27. Schmidtke AJ, Hanson ND. 2006. Model system to evaluate the effect of ampD mutations on AmpC-mediated β-lactam resistance. Antimicrob. Agents Chemother. 50:2030-2037.
28. Lindberg F, Westman L, Normark S. 1985. Regulatory components in Citrobacter freundii ampC β-lactamase induction. Proc. Natl. Acad. Sci. U. S. A. 82:4620-4624.
29. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing; 22nd informational supplement M100-S22. CLSI, Wayne, PA.
30. Carrasco-López C, Rojas-Altuve A, Zhang W, Hesek D, Lee M, Barbe S, André I, Ferrer P, Silva-Martin N, Castro GR, Martínez-Ripoll M, Mobashery S, Hermoso JA. 2011. Crystal structures of bacterial peptidoglycan amidase AmpD and an unprecedented activation mechanism. J. Biol. Chem. 286:31714-31722.
31. Hesek D, Lee M, Zhang W, Noll BC, Mobashery S. 2009. Total synthesis of N-acetylglucosamine-1,6-anhydro-N-acetylmuramylpentapeptide and evaluation of its turnover by AmpD from Escherichia coli. J. Am. Chem. Soc. 131:5187-5193.
32. Lee M, Zhang W, Hesek D, Noll BC, Boggess B, Mobashery S. 2009. Bacterial AmpD at the crossroads of peptidoglycan recycling and manifestation of antibiotic resistance. J. Am. Chem. Soc. 131:8742-8743.
33. Huang YW, Hu RM, Lin CW, Chung TC, Yang TC. 2012. NagZdependent and NagZ-independent mechanisms for β-lactamase expression in Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 56:1936-1941.
34. Lira F, Hernández A, Belda E, Sánchez MB, Moya A, Silva FJ, Martínez JL. 2012. Whole-genome sequence of Stenotrophomonas maltophilia D457, a clinical isolate and a model strain. J. Bacteriol. 194:3563-3564.
35. Papadopoulos JS, Agarwala R. 2007. COBALT: constraint-based alignment tool for multiple protein sequences. Bioinformatics 23:1073-1079.
36. Dietz H, Pfeifle D, Wiedemann B. 1997. The signal molecule for β-lactamase induction in Enterobacter cloacae is the anhydromuramylpentapeptide. Antimicrob. Agents Chemother. 41:2113-2120.
37. Mark BL, Vocadlo DJ, Oliver A. 2011. Providing β-lactams a helping hand: targeting the AmpC β-lactamase induction pathway. Future Microbiol. 6:1415-1427.